tiprankstipranks
Generic Sweden AB (SE:GENI)
:GENI
Sweden Market
Want to see SE:GENI full AI Analyst Report?

Generic Sweden AB (GENI) AI Stock Analysis

2 Followers

Top Page

SE:GENI

Generic Sweden AB

(GENI)

Select Model
Select Model
Select Model
Outperform 83 (OpenAI - Gpt-5.6Sol)
Rating:83Outperform
Price Target:
kr47.00
▲(1.18% Upside)
Action:Reiterated
Date:08/21/26
The score is driven primarily by strong financial performance (profitability, debt-free balance sheet, and solid free-cash-flow conversion). Valuation is supportive with a moderate P/E and a strong dividend yield, while technicals are positive but not decisively strong enough to push the score higher.
Positive Factors
Strong profitability
Sustained double-digit operating and net margins indicate an efficient software business with meaningful earnings power. This profitability can support reinvestment, shareholder distributions and resilience if growth moderates over the next several quarters.
Negative Factors
Gross margin pressure
The lower gross margin suggests rising delivery costs, pricing pressure or a less favorable revenue mix. If persistent, it could constrain operating leverage and reduce the company’s ability to convert future sales growth into higher profits.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong profitability
Sustained double-digit operating and net margins indicate an efficient software business with meaningful earnings power. This profitability can support reinvestment, shareholder distributions and resilience if growth moderates over the next several quarters.
Read all positive factors

Generic Sweden AB (GENI) vs. iShares MSCI Sweden ETF (EWD)

Generic Sweden AB Business Overview & Revenue Model

Company Description
Operating as a technology firm, Generic Sweden AB delivers messaging functionalities compatible with any application. The company additionally furnishes a comprehensive platform dedicated to digital communication services. Established in 1993, its...

Generic Sweden AB Financial Statement Overview

Summary
Strong overall fundamentals: solid profitability (TTM operating margin ~20.7%, net margin ~16.5%), very conservative capital structure with zero debt, and healthy cash conversion (TTM operating cash flow slightly above net income; free cash flow ~93% of net income). Key offsets are some gross margin compression versus earlier years and a recent decline in equity/assets that is worth monitoring.
Income Statement
86
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
84
Very Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue192.18M183.71M176.45M142.59M127.73M114.23M
Gross Profit45.46M38.81M44.72M38.27M35.54M31.93M
EBITDA40.19M39.58M35.52M30.16M26.75M24.16M
Net Income31.79M31.04M27.25M23.31M20.45M18.13M
Balance Sheet
Total Assets97.14M105.14M88.97M77.42M68.04M59.42M
Cash, Cash Equivalents and Short-Term Investments45.78M58.24M40.62M37.20M32.60M31.07M
Total Debt0.000.000.000.000.000.00
Total Liabilities36.39M38.55M33.75M31.01M29.57M29.11M
Stockholders Equity60.74M66.59M55.22M46.41M38.47M30.31M
Cash Flow
Free Cash Flow31.12M38.98M21.85M19.97M13.82M18.44M
Operating Cash Flow32.79M39.73M24.06M21.84M16.85M19.89M
Investing Cash Flow12.33M-2.44M9.79M-13.87M-3.03M-1.45M
Financing Cash Flow-21.51M-19.67M-18.44M-15.37M-12.29M-9.83M

Generic Sweden AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
kr496.60M15.663.48%6.76%1.88%
72
Outperform
kr483.26M21.107.40%10.39%30.32%
71
Outperform
kr3.30B27.6732.94%1.41%8.48%19.59%
69
Neutral
kr850.07M3.241.92%-40.78%2331.24%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
55
Neutral
kr487.40M-24.5721.86%74.32%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:GENI
Generic Sweden AB
40.40
-8.82
-17.93%
SE:DONE
24SevenOffice
8.10
-2.34
-22.41%
SE:LIME
Lime Technologies AB
248.50
-89.70
-26.52%
SE:UPSALE
Upsales Technology AB
28.70
-5.13
-15.15%
SE:ONEF
Oneflow AB
17.20
-7.90
-31.47%
SE:LASER
FormPipe Software AB
29.00
0.98
3.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 21, 2026